Aristo Bio-Tech and Lifescience Ltd. logo

Aristo Bio-Tech and Lifescience was incorporated on March 17, 2005. It is an agrochemical company engaged in manufacturing, formulating, supplying and packaging various pesticides such as insecticides, herbicides, fungicides, plant growth regulators and a variety of other agrochemicals for India and for export.

Bidding Dates
16 Jan 2023 - 19 Jan 2023
Subscription
217.67x Oversubscribed
Minimum InvestmentMinimum LotMaximum LotLot SizeNumber of SharesIssue PricePost Issue Promoter Holding %Issue SizeIPO Document
₹1,15,2001116001.8 M₹7273.37 %₹130.5 MRHP DOC

Aristo Bio-Tech IPO SUBSCRIPTION STATUS

19 Jan '23
Total217.67x
Retail Individual Investor149.51x
HNI (NII) Investors285.84x
Qualified Institutional Buyers-

Aristo Bio-Tech IPO overall subscription rate was 217.67 times the total available shares

Aristo Bio-Tech IPO retail subscription rate was 149.51 times in the retail segment

Aristo Bio-Tech IPO non-institutional investor subscription rate was 285.84 times in the non-institutional investor category

DayRetail Individual InvestorHNI (NII) InvestorsQualified Institutional Buyers
Category Reservation50%50%-
19 Jan 2023
(Day 4)
149.51x285.84x-
18 Jan 2023
(Day 3)
44.14x18.62x-
17 Jan 2023
(Day 2)
15.38x3.45x-
16 Jan 2023
(Day 1)
3.24x1.09x-

Aristo Bio-Tech FINANCIALS

Period Net Profit (Rs in millions) Revenue from Operations (Rs in millions) Cash Flow from Operations (Rs in millions) Free Cash Flow (Rs in millions)
H1FY23 25.9 1,515.6 27.9 5.5
FY22 14.6 1,911.7 68.2 35.8
FY21 10.8 1,960.6 22.8 8.5
FY20 10.1 2,355.0 14.1 5.4

Aristo Bio-Tech IPO SUBSCRIPTION STATUS DETAILS

Aristo Bio-Tech had 1.8 M shares on offer

Aristo Bio-Tech IPO offer price was ₹72

Aristo Bio-Tech IPO minimum Investment was115200

Aristo Bio-Tech IPO issue size was ₹ 130.5 M

Aristo Bio-Tech had a minimum lot size of 1600 Shares per application

Aristo Bio-Tech NUMBER OF SHARES ON OFFER

Total1.8 M
Fresh Issue1.8 M
Offer for Sale0
Post Issue Promoter Holding %73.37 %

Aristo Bio-Tech IPO IMPORTANT DATES

Issue Open Date16 Jan 2023
Issue close Date19 Jan 2023
Allotment Date24 Jan 2023
Refund Date25 Jan 2023
Demat Account Credit Date26 Jan 2023
Listing Date30 Jan 2023
Listing on Exchange(s)NSE
Aristo Bio-Tech Allotment StatusExchange

Aristo Bio-Tech IPO subscription opened on 16 Jan 2023, and closed on 19 Jan 2023

IPO allotment for Aristo Bio-Tech was finalized on Tuesday, 24 Jan 2023

IPO listing for Aristo Bio-Tech was on NSE on Monday, 30 Jan 2023

Aristo Bio-Tech IPO LISTING GAINS

Issue Price (adjusted)72.0
Listing Open Price80.0
Listing Close Price84.0
Listing Gain%11.1%
Current Gain%51.8%

Aristo Bio-Tech Peer

StockStock PriceMarket Cap (Rs crore)PE TTMPEG TTMPS TTMROE%ROA%Annual Revenue (Rs crore)Annual Revenue Growth %Annual Net Profit (Rs crore)Annual Net Profit Growth %EPS TTMEPS TTM Growth %
Aristo Bio-Tech and Lifescience Ltd.109.374.410.40.10.216.14.6364.214.37.276.810.676.8
UPL Ltd.57348370.925.10.40.95.525250211.41922114.322.861.5
PI Industries Ltd.2774.642095.731.9-1.66.311.89.87024.4-15.61320.8-20.487.1-20.4
Sumitomo Chemical India Ltd.5332660245.911.58.21612.133853.65437.411.64
Bayer Cropscience Ltd.4177.218773.225.61.13.423.212.157703.2689.221.3162.923.6
Sharda Cropchem Ltd.8147344.411.70.21.421.711.85409.823.5680.9123.769.449.1

Aristo Bio-Tech INFORMATION ON IPO ISSUE

About Aristo Bio-Tech

Aristo Bio-Tech and Lifescience was incorporated on March 17, 2005. It is an agrochemical company engaged in manufacturing, formulating, supplying and packaging various pesticides such as insecticides, herbicides, fungicides, plant growth regulators and a variety of other agrochemicals for India and for export.

Object of the Issue

  1. To meet working capital requirement
  2. General corporate purpose
  3. To meet the issue expenses

Aristo Bio-Tech - PROMOTERS

Name
Narendra Singh Barhat
Kusum Narendra Singh Barhat
Ketankumar Harkantbhai Joshi

Aristo Bio-Tech Lead Manager to the Issue

Beeline Capital Advisors Private Limited

mb@beelinemb.com

Aristo Bio-Tech Registrar to the Issue

Link Intime India Private Limited

aristobio.ipo@linkintime.co.in

Aristo Bio-Tech Strengths

Experienced management

The management and employees combine expertise and experience to outline plans for the company's future development. The promoters have significant industry experience and have been instrumental in the consistent growth of the company

Strength

Quality assurance

The company is ISO 9001: 2015 certified for a quality management system which conforms to the quality standards for manufacturing agrochemicals and pesticides, and assigned SMERA SME 3 for good creditworthiness

Strength

Innovative ideas

The company is focusing on expanding its existing range of products and coming out with new business ideas

Strength

Scalable business model

The business model is order-driven and comprises of optimum utilization of existing resources

Strength

Aristo Bio-Tech Risks

Highly volatile prices

Highly volatile prices of agrochemicals and other products which the company manufactures may cause losses if it is unable to maintain an appropriate time span between the purchase of material and the sale of the same

Risk

Requires certain approvals and licenses

The company requires certain approvals and licenses, including registrations from the Central Insecticides Board and Registration Committee, and failure to successfully obtain them would adversely affect the operations, results of operations and financial condition

Risk

Outstanding legal proceedings

There are outstanding legal proceedings involving the company, its directors and promoters. Any adverse decision in such proceedings may have a material adverse effect on the business, results of operations and financial condition

Risk

Cyclical business

The business is subject to climatic conditions and is cyclical in nature

Risk

IPO FAQs

  • The promoters of the company are Narendra Singh Barhat, Kusum Narendra Singh Barhat and Ketankumar Harkantbhai Joshi.

  • The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.

  • The price band of the IPO is Rs 72.0 - 72.0.

  • The IPO application opens on Jan 16, 2023 and closes on Jan 19, 2023.

  • The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.

  • For all category investors, the minimum application amount for this IPO is Rs. 115,200.0, the maximum value for this IPO is Rs 115,200.0.

  • This IPO will be allotted on Jan 24, 2023.

  • The refund will be credited to your account on Jan 25, 2023.

  • The allotted shares will be credited to your demat on Jan 26, 2023.

  • Aristo Bio-Tech and Lifescience Ltd.’s shares listed on the stock exchanges on Jan 30, 2023.